US Patent 10716818 Oncolytic virotherapy and immunotherapy
Patent 10716818 was granted and assigned to Baylor College of Medicine on July, 2020 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10716818 Oncolytic virotherapy and immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
